Tag: secondCrew

Eva joined MC Services in 2018 and has more than 20 years of experience in Public Relations. Prior to joining MC Services, Eva worked with Ketchum Pleon, a global PR agency, for 14 years, where she played a leading role as a Business Director in the Company’s Healthcare department. She also previously worked at Fleishman-Hillard, serving clients from the pharmaceutical and insurance industries. Her experience includes working with several top 20 pharmaceutical companies, including in the areas of cardiology, diabetes, gastrointestinal diseases, pain, vaccines, and nutritional supplements (OTC). Eva holds a degree in law. In addition to corporate communications, Eva focuses on supporting clients’ commercialization activities, including the strategic positioning of new drugs and healthcare products. Tasks range from pre-approval market-shaping activities for potential prescribers to launch communications, as well as patient awareness, cross-marketing, crisis prevention and issues management.

Caro is Executive Director at MC Services. She joined the firm in 2011 and has taken on roles of increasing responsibility during her tenure. Clients rely on her strategic consulting, communications planning, crisis preparedness training and media relations skills. She is responsible for a wide range of accounts from large pharma to small biotech companies. Caro was instrumental in establishing the Düsseldorf office and building and developing the team. She studied English and journalism at the University of Leipzig, including a semester at the University of Wales in the UK. She also was a freelance writer for local newspapers and special interest magazines.

Shaun joined MC Services in 2009. He spent the last 20 years writing on and advising companies in the Life Sciences industry. Previously, he has been a director of Innovator Capital Limited, a boutique investment bank, and before this he was a director of Capital MS&L. Shaun focused on Public and Investor Relations for companies in the sector, advising on all aspects of their communications strategies. Prior to this, he spent over eight years as a reporter and later news editor and senior writer with BioCentury covering the global biotech and pharma industry. Shaun has written about and advised on major stories covering client companies and therapeutic subjects. Shaun is an IT specialist and economist by training. Besides his knowledge of the Life Sciences industry, Shaun’s sector expertise includes Renewable Energies, Cleantech and Economic Development. Shaun is FSA authorized.

Laurie joined MC Services in 2016 and has 25 years of investor relations and corporate communications experience. Prior to joining MC Services, Laurie led US IR and corporate communications at the French biotech, Transgene. She previously served as head of IR and corporate communications for immunotherapy company, Agennix, and led US IR and corporate communications for the oncology company, GPC Biotech. She began her IR career at Organogenesis, a tissue engineering firm. She has spearheaded a wide range of initiatives, including raising awareness and understanding of the companies for which she worked in the investment community and press. She has led IR and PR activities around a variety of major news events, including Phase III data readouts, M&A and leadership change, and has been a key team member for major financings, including a Nasdaq listing. Laurie has an MBA from Simmons University and a BA in Russian from Middlebury College.

Solveigh joined MC Services in 2013 with over 14 years of experience in capital markets with a track-record of over 10 years as Director Investor Relations/Public Relations with QIAGEN, a global market leading company with dual-listings on the Deutsche Börse and NASDAQ exchanges. In this position, she was responsible for the company’s communications strategy during more than 20 M&A deals and numerous capital raising activities. Under her direction, the QIAGEN team was repeatedly awarded for its IR performance. Prior to joining QIAGEN, she worked as a sell-side analyst and life sciences sector specialist with former WestLB.